CCR3 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

293 results for “CCR3”

Trials

View all 211 →

Oral GW766944 (Oral CCR3 Antagonist)

60 participants · First posted Jul 12, 2010

GW824575 First Time in Human

16 participants · First posted Mar 13, 2012

Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.

22 participants · First posted Dec 6, 2018

Drugs

View all 70 →

CCR3 modulators (Boehringer Ingelheim)

CCR8 Mab

News

View all 12 →

HKeyBio Launches HKEY-ExE™ 1.0 Preclinical Framework to Accelerate Drug Development for Eosinophilic Gastrointestinal Disorders

Chemomab Secures Global Patent Protection for CM-101 Antibody Targeting Primary Sclerosing Cholangitis

Oral CCR4 Antagonist RPT193 Shows Promise in Atopic Dermatitis Phase 1 Trial

Page 1 of 30